INX-315

• Target :

  CDK|||Early 2 Factor (E2F)

• Related Pathways :

  Cell Cycle/Checkpoint

• Purity :

  0.9988

• Bioactivity :

  INX-315 is an orally active, selective CDK2 inhibitor that induces cell cycle arrest and senescence in solid tumours, suppresses E2F target gene expression, and exhibits anticancer activity in ccne1-amplified cancers and cdk4/6i-resistant intraductal breast cancer models.

• Smiles :

  O=C1NNC2=CC=3C=NC(=NC3N2C14CCCCC4)NC5=CC=C(C=C5)S(=O)(=O)N

• Molecular Formula :

  C19H21N7O3S

• Molecular Weight :

  427.48

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2745060-92-6